Literature DB >> 14938444

Effect of benemid (p-[di-n-propylsulfamyl]-benzoic acid) on urate clearance and other discrete renal functions in gouty subjects.

J H SIROTA, T F YU, A B GUTMAN.   

Abstract

Entities:  

Keywords:  BENEMID/effects; GOUT/metabolism in; URIC ACID/metabolism

Mesh：

Substances：

Year:  1952        PMID： 14938444      PMCID： PMC436462          DOI： 10.1172/JCI102651

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  15 in total

1.  Diurnal variation in electrolyte excretion.

Authors:  S W STANBURY; A E THOMSON
Journal:  Clin Sci       Date:  1951-08       Impact factor: 6.124

2.  The clinical and metabolic effects of benemid in patients with gout.

Authors:  J H TALBOTT; C BISHOP; B M NORCROSS; L M LOCKIE
Journal:  Trans Assoc Am Physicians       Date:  1951

3.  Benemid (p-di-n-propylsulfamyl)-benzoic acid) as uricosuric agent in chronic gouty arthritis.

Authors:  A B GUTMAN; T F YU
Journal:  Trans Assoc Am Physicians       Date:  1951

4.  'Benemid,' p-(di-n-propylsulfamyl)-benzoic acid; its renal affinity and its elimination.

Authors:  K H BEYER; H F RUSSO; E K TILLSON; A K MILLER; W F VERWEY; S R GASS
Journal:  Am J Physiol       Date:  1951-09

5.  The effect of benemid (P-[DI-N-propylsulfamyl]-benzoic acid) on uric acid metabolism in one normal and one gouty subject.

Authors:  C BISHOP; R RAND; J H TALBOTT
Journal:  J Clin Invest       Date:  1951-08       Impact factor: 14.808

6.  Effectiveness of a new compound, benemid, in elevating serum penicillin concentrations.

Authors:  J M BURNELL; W M M KIRBY
Journal:  J Clin Invest       Date:  1951-07       Impact factor: 14.808

7.  URIC acid metabolism and gout.

Authors: 
Journal:  Am J Med       Date:  1950-12       Impact factor: 4.965

8.  Hypouricemia: with evidence for tubular elimination of uric acid.

Authors:  E PRAETORIUS; J E KIRK
Journal:  J Lab Clin Med       Date:  1950-06

9.  The renal mechanism for urate excretion in man.

Authors:  R W BERLINER; J G HILTON; T F YU; T J KENNEDY
Journal:  J Clin Invest       Date:  1950-04       Impact factor: 14.808

10.  Diurnal variations of renal function in man.

Authors:  J H SIROTA; D S BALDWIN; H VILLARREAL
Journal:  J Clin Invest       Date:  1950-02       Impact factor: 14.808
View more
  19 in total

1.  Study of the paradoxical effects of salicylate in low, intermediate and high dosage on the renal mechanisms for excretion of urate in man.

Authors:  T F YU; A B GUTMAN
Journal:  J Clin Invest       Date:  1959-08       Impact factor: 14.808

2.  MUTUAL SUPPRESSION OF THE URICOSURIC EFFECTS OF SULFINPYRAZONE AND SALICYLATE: A STUDY IN INTERACTIONS BETWEEN DRUGS.

Authors:  T F YUE; P G DAYTON; A B GUTMAN
Journal:  J Clin Invest       Date:  1963-08       Impact factor: 14.808

3.  A study, by simultaneous clearance techniques, of salicylate excretion in man: effect of alkalinization of the urine by bicarbonate administration; effect of probenecid.

Authors:  A GUTMAN; T F YU; J H SIROTA
Journal:  J Clin Invest       Date:  1955-05       Impact factor: 14.808

4.  The uricosuria and orotic aciduria induced by 6-azauridine.

Authors:  H J FALLON; E FREI; J BLOCK; J E SEEGMILLER
Journal:  J Clin Invest       Date:  1961-10       Impact factor: 14.808

5.  Studies of the uricogenic effect of 2-substituted thiadiazoles in man.

Authors:  I H KRAKOFF; M E BALIS
Journal:  J Clin Invest       Date:  1959-06       Impact factor: 14.808

6.  Overproduction of uric acid as the cause of hyperuricemia in primary gout.

Authors:  J B WYNGAARDEN
Journal:  J Clin Invest       Date:  1957-10       Impact factor: 14.808

7.  Renal function in Wilson's disease.

Authors:  A G BEARN; T F YU; A B GUTMAN
Journal:  J Clin Invest       Date:  1957-07       Impact factor: 14.808

8.  Renal regulation of uric acid excretion in normal and gouty man; modification by uricosuric agents.

Authors:  A B GUTMAN; T F YU
Journal:  Bull N Y Acad Med       Date:  1958-05

9.  Evaluation of uricosuric agents in chronic gout.

Authors:  M A OGRYZLO; J HARRISON
Journal:  Ann Rheum Dis       Date:  1957-12       Impact factor: 19.103

10.  Effect of a phenylbutazone analog (4-[phenylthioethyl]-1, 2-diphenyl 3, 5-pyrazolidinedione) on urate clearance and other discrete renal functions in gouty subjects; evaluation as uricosuric agent.

Authors:  T F YU; B C PATON; T CHENKIN; J J BURNS; B B BRODIE; A B GUTMAN
Journal:  J Clin Invest       Date:  1956-04       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.